AstraZeneca Company Summary |
|
AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
|
|
Key Developments: AstraZeneca
 |
Biota Holdings Limited (ASX:BTA) RSV Licence Assigned to Astrazeneca And Territories Expanded
AUG 25, 2008 11:16 - Article Views: 2,040
Biota Holdings Limited (ASX:BTA) and AstraZeneca (LON:AZN) today announced that the 2005 Collaboration and License Agreement with MedImmune has been assigned to AstraZeneca. AstraZeneca has also secured the rights to a number of Asian and Pacific territories not held by MedImmune under the original agreement and for which Biota will receive an additional US$3.5 million payment, plus future royalties. |
 |
451 COMPANY PROFILE VIEWS |
|
This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 26) (Since Published: 451)
|
|
|
|
